Newbridge Financial Services Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31K Hold
114
﹤0.01% 901
2026
Q1
$8.12K Sell
114
-4
-3% -$315 ﹤0.01% 829
2025
Q4
$9.69K Buy
118
+4
+4% +$312 ﹤0.01% 788
2025
Q3
$8.57K Sell
114
-14
-11% -$1.04K ﹤0.01% 931
2025
Q2
$9.49K Buy
128
+16
+14% +$1.11K ﹤0.01% 904
2025
Q1
$9.04K Sell
112
-64
-36% -$5.5K ﹤0.01% 701
2024
Q4
$13.8K Buy
176
+30
+21% +$2.55K ﹤0.01% 676
2024
Q3
$13.7K Sell
146
-33
-18% -$2.77K ﹤0.01% 398
2024
Q2
$13.9K Sell
179
-15
-8% -$1.22K 0.01% 645
2024
Q1
$17.6K Sell
194
-111
-36% -$9.24K 0.01% 633
2023
Q4
$23.6K Sell
305
-239
-44% -$16.7K 0.01% 551
2023
Q3
$37K Sell
544
-162
-23% -$11.8K 0.02% 491
2023
Q2
$57.4K Sell
706
-238
-25% -$19K 0.03% 423
2023
Q1
$77.4K Buy
+944
New +$67.4K 0.04% 364

Other funds holding GEHC

Newbridge Financial Services Group's GEHC Position: Q2 2026 in Review

Newbridge Financial Services Group held its GE HealthCare (GEHC) position steady in Q2 2026 at 114 shares worth $7.31K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Newbridge Financial Services Group first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $77.4K in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Newbridge Financial Services Group held 114 shares of GE HealthCare worth $7.31K as of Q2 2026.
  • Newbridge Financial Services Group left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #901 holding.
  • Newbridge Financial Services Group first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Newbridge Financial Services Group's GE HealthCare position peaked at $77.4K in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.